Table 1.
Baseline patient characteristics (n = 13*)
| Characteristics | |
|---|---|
| Age, years, median (range) | 57 (30–76) |
| Sex, male, n (%) | 8 (62) |
| Disease stage, n (%) | |
| IV | 13 (100) |
| ECOG performance status, n (%) | |
| 0 | 9 (69) |
| 1 | 4 (31) |
| Metastatic sites, n (%) | |
| Liver | 13* (100) |
| Brain | 1 (7) |
| LDH >2× ULN, n (%) | 3 (23) |
| Number of prior systemic therapies, median (range) | 2 (1–4) |
| Chemotherapy, n (%) | 12 (92) |
| Immunotherapy, n (%) | 3 (23) |
| Chemo-immunotherapy, n (%) | 3 (23) |
ECOG Eastern cooperative oncology group, LDH lactate dehydrogenase, ULN upper limit of normal
* Evidence in 12, history in 1